Targeted Therapy Market Expansion Outlook Through 2030 With Revenue Growth Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Growth In Market Size Of The Targeted Therapy Market During 2026–2030?

The targeted therapy market size has shown strong growth in recent years. It is forecast to expand from $109.99 billion in 2025 to $118.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. This historical growth can be ascribed to an increase in global cancer incidence, expanded funding for oncology research, the rising adoption of monoclonal antibodies, advancements in molecular biology research, and the increasing approval of targeted cancer drugs.

The targeted therapy market size is expected to experience significant growth in the coming years. It is projected to expand to $158.2 billion by 2030, with a compound annual growth rate (CAGR) of 7.6%. This projected growth can be attributed to factors such as increased investments in personalized medicine, the expanding use of AI-driven drug discovery, a wider adoption of precision diagnostics, a rising demand for less toxic cancer therapies, and increased clinical trial activity in oncology. Key trends anticipated during the forecast period include the increasing development of precision oncology drugs, a growing adoption of biomarker-based treatment selection, the expansion of combination targeted therapies, the increasing use of companion diagnostics, and an enhanced focus on tumor-specific drug design.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

What Major Growth Factors Are Impacting The Targeted Therapy Market?

The growing incidence of cancer is anticipated to fuel the expansion of the targeted therapy market. Cancer refers to conditions characterized by uncontrolled division of abnormal cells that can invade adjacent tissues. Targeted therapy effectively disrupts signals that promote cancer cell growth or induces cancer cells to self-destruct. It utilizes drugs to specifically target proteins and genes essential for cancer cell proliferation and survival, thereby boosting its requirement. For example, data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, showed that in January 2024, cancer cases rose to 2,001,140 from 1,958,310 in 2023, an increase of 2.19%. Consequently, the rising prevalence of cancer will stimulate the growth of the targeted therapy market.

Which Segment Divisions Form The Structure Of The Targeted Therapy Market?

The targeted therapy market covered in this report is segmented –

1) By Type: Small Molecule Medicines, Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

Subsegments:

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

What Trends Are Influencing The Targeted Therapy Market Outlook?

Leading companies in the tadalafil market are focusing on developing innovative formulations, such as combination therapy, to enhance treatment effectiveness, improve patient adherence, and expand their market presence in managing erectile dysfunction and pulmonary arterial hypertension. Combination therapy refers to the concurrent use of two or more medications or treatments to improve therapeutic outcomes, boost efficacy, and address multiple aspects of a disease or condition. For example, in March 2024, Johnson & Johnson, a US-based healthcare company, announced FDA approval for OPSYNVI, a single-tablet therapy that combines macitentan, an endothelin receptor antagonist (ERA), and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. This novel treatment is indicated for the chronic management of pulmonary arterial hypertension (PAH) (WHO Group I) in adult patients categorized under WHO functional class II-III. OPSYNVI is suitable for patients new to treatment and those currently on ERA, PDE5 inhibitors, or both. Additionally, it offers a simplified option for patients already stable on macitentan 10 mg and tadalafil 40 mg (20 mg x 2) when administered separately.

Who Are The Prominent Players Across The Targeted Therapy Market?

Major companies operating in the targeted therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

Access The Complete Targeted Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Which Region Has The Strongest Presence In The Targeted Therapy Market?

North America was the largest region in the targeted therapy market in 2025. The regions covered in the targeted therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Targeted Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9129&type=smp

Browse Through More Reports Similar to the Global Targeted Therapy Market 2026, By The Business Research Company

Music Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/music-therapy-global-market-report

Neoantigen Targeted Therapies Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report

Addictions Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795